Evaluation of umbilical cord blood CD34⁺ hematopoietic stem cell expansion in co-culture with bone marrow mesenchymal stem cells in the presence of TEPA

References

• Conrad PD, Emerson SG. Ex vivo expansion of hematopoietic cells from umbilical cord blood for clinical transplantation. J Leukoc Biol. 1998;64:147–55.
   PubMed Web of Science ®Google Scholar
• Lim M, Ye H, Panoskaltsis N, Drakakis EM, Yue X, Cass AE, et al. Intelligent bioprocessing for hematopoietic cell cultures using monitoring and design of experiments. Biotechnol Adv. 2007;25(4):353–68.
   PubMed Web of Science ®Google Scholar
• Gordon MY. Stem cells for regenerative medicine – biological attributes and clinical application. Exp Hematol. 2008;36(6):726–32.
   PubMed Web of Science ®Google Scholar
• Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105–11.
   PubMed Web of Science ®Google Scholar
• Kondo M, Wagers AJ, Manz MG, Prohaska SS, Scherer DC, Beilhack GF, et al. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol. 2003;21:759–806.
   PubMed Web of Science ®Google Scholar
• Lane TA. Umbilical cord blood grafts for hematopoietic transplantation in adults: a cup half empty or half full? Transfusion. 2005;45(6):1027–34.
   PubMed Web of Science ®Google Scholar
• Gluckman E, Rocha V, Chevret S. Results of unrelated umbilical cord blood hematopoietic stem cell transplantation. Rev Clin Exp Hematol. 2001;5(2):87–99.
   PubMedGoogle Scholar
• Migliaccio AR, Adamson JW, Stevens CE, Dobrila NL, Carrier CM, Rubinstein P. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood. 2000;96:2717–22.
   PubMed Web of Science ®Google Scholar
• Gilmore GL, Depasquale DK, Lister J, Shadduck RK. Ex vivo expansion of human umbilical cord blood and peripheral blood CD34+ hematopoietic stem cells. Exp Hematol. 2000;28(11):1297–305.
   PubMed Web of Science ®Google Scholar
• Kelly SS, Sola CB, de Lima M, Shpall E. Ex vivo expansion of cord blood. Bone Marrow Transplant. 2009;44(10):673–81.
   PubMed Web of Science ®Google Scholar
• Yao CL, Chu IM, Hsieh TB, Hwang SM. A systematic strategy to optimize ex vivo expansion medium for human hematopoietic stem cells derived from umbilical cord blood mononuclear cells. Exp Hematol. 2004;32(8):720–7.
   PubMed Web of Science ®Google Scholar
• Rocha V, Wagner JE, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM, et al. Graft versus host disease in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med. 2000;342:1846–54.
   PubMed Web of Science ®Google Scholar
• Shpall EJ, Quinones R, Giller R, Zeng C, Baron AE, Jones RB, et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant. 2002;8(7):368–76.
   PubMed Web of Science ®Google Scholar
• Sorrentino BP. Clinical strategies for expansion of haematopoietic stem cells. Nat Rev Immunol. 2004;4(11):878–88.
   PubMed Web of Science ®Google Scholar
• Martinez-Agosto JA, Mikkola HK, Hartenstein V, Banerjee U. The hematopoietic stem cell and its niche: a comparative view. Genes Dev. 2007;21:3044–60.
   PubMed Web of Science ®Google Scholar
• Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003;425(6960):778–9.
   PubMed Web of Science ®Google Scholar
• Robinson S, Niu T, de Lima M, Ng J, Yang H, McMannis J, et al. Ex vivo expansion of umbilical cord blood. Cytotherapy. 2005;7(3):243–50.
   PubMed Web of Science ®Google Scholar
• Gottschling S, Saffrich R, Seckinger A, Krause U, Horsch K, Miesala K, et al. Human mesenchymal stromal cells regulate initial self-renewing divisions of hematopoietic progenitor cells by a beta1-integrin-dependent mechanism. Stem Cell. 2007;25(3):798–806.
   PubMed Web of Science ®Google Scholar
• Jing D, Fonseca AV, Alakel N, Fierro FA, Muller K, Bornhauser M, et al. Hematopoietic stem cells in co-culture with mesenchymalstromal cells – modeling the niche compartments in vitro. Hematologica. 2010;95(4):542–50.
   PubMed Web of Science ®Google Scholar
• Breems DA, Blokland EA, Siebel KE, Mayen AE, Engels LJ, Ploemacher RE. Stroma-contact prevents loss of hematopoietic stem cell quality during ex vivo expansion of CD34+ mobilized peripheral blood stem cells. Blood. 1998;91(1):111–7.
   PubMed Web of Science ®Google Scholar
• Blank U, Karlsson G, Karlsson S. Signaling pathways governing stem cell fate. Blood. 2008;111:492–503.
   PubMed Web of Science ®Google Scholar
• Huang X, Pierce LJ, Cobine PA, Winge DR, Spangrude GJ. Copper modulates the differentiation of mouse hematopoietic progenitor cells in culture. Cell Transplant. 2009;18(8):887–97.
   PubMed Web of Science ®Google Scholar
• Peled T, Landau E, Prus E, Treves AJ, Nagler A, Fibach E. Cellular copper content modulates differentiation and self-renewal in cultures of cord blood-derived CD34+ cells. Br J Haematol. 2002;116:655–61.
   PubMed Web of Science ®Google Scholar
• Peled T, Landau E, Mandel J, Glukhman E, Goudsmid NR, Nagler A, et al. Linear polyamine copper chelator tetraethylenepentamine augments long-term ex vivo expansion of cord blood-derived CD34+ cells and increases their engraftment potential in NOD/SCID mice. Exp Hematol. 2004;32(6):547–55.
   PubMed Web of Science ®Google Scholar
• Peled T, Glukhman E, Hasson N, Adi S, Assor H, Yudin D, et al. Chelatable cellular copper modulates differentiation and self-renewal of cord blood-derived hematopoietic progenitor cells. Exp Hematol. 2005;33(10):1092–100.
   PubMed Web of Science ®Google Scholar
• Percival SS, Layden-Patrice M. HL-60 cells can be made copper deficient by incubating with tetraethylenepentamine. J Nutr. 1992;122(12):2424–9.
   PubMed Web of Science ®Google Scholar
• Bae B, Percival S. Copper uptake and intracellular distribution during retinoic acid-induced differentiation of HL-60 Cells. J Nutr Biochem. 1994;5(9):457–61.
   Web of Science ®Google Scholar
• Huang ZL, Failla ML, Reeves PG. Differentiation of human U937promonocytic cells is impaired by moderate copper deficiency. Exp Biol Med. (Maywood) 2001;226(3):222–8.
   PubMed Web of Science ®Google Scholar
• Yang S, Cai H, Jin H, Fan J, Tan WS. Hematopoietic reconstitution of CD34+ cells derived from short-term cultured cord blood mononuclear cells. Biotechnol. Bioprocess Eng. 2009;14(4):429–35.
   Web of Science ®Google Scholar
• Oswald J, Boxberger S, Jørgensen B, Feldmann S, Ehninger G, Bornhäuser M, et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells. 2004;22(3):377–84.
   PubMed Web of Science ®Google Scholar
• www.Sigmaaldrich.com
   Google Scholar
• Robinson SN, Ng J, Niu T, Yang H, McMannis JD, Karandish S, et al. Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells. Bone Marrow Transplant. 2006;37(4):359–66.
   PubMed Web of Science ®Google Scholar
• Almeida-Porada G, Brown RL, MacKintosh FR, Zanjani ED. Evaluation of serum free culture conditions able to support the ex vivo expansion and engraftment of human hematopoietic stem cells in the human-to-sheep xenograft model. J Hematother Stem Cell Res. 2000;9(5):683–93.
   PubMedGoogle Scholar
• Jang YK, Jung DH, Jung MH, Kim DH, Yoo KH, Sung KW, et al. Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells. Ann Hematol. 2006;85(4):212–25.
   PubMed Web of Science ®Google Scholar
• Bachier CR, Gokmen E, Teale J, Lanzkron S, Childs C, Franklin W, et al. Ex-vivo expansion of bone marrow progenitor cells for hematopoietic reconstitution following high dose chemotherapy for breast cancer. Exp Hematol. 1999;27(4):615–23.
   PubMed Web of Science ®Google Scholar
• Weissman IL. Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science. 2000;287(5457):1442–6.
   PubMed Web of Science ®Google Scholar
• Broxmeyer HE, Douglas GW, Hangoc G, Cooper S, Bard J, English D, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA. 1989;86(10):3828.
   PubMed Web of Science ®Google Scholar
• da Silva CL, Gonçalves R, Crapnell KB, Cabral JM, Zanjani ED, Almeida-Porada G. A human stromal-based serum-free culture system supports the ex vivo expansion/maintenance of bone marrow and cord blood hematopoietic stem/progenitor cells. Exp Hematol. 2005;33(7):828–35.
   PubMed Web of Science ®Google Scholar
• Köhler T, Plettig R, Wetzstein W, Schaffer B, Ordemann R, Nagels HO, et al. Defining optimum conditions for the ex vivo expansion of human umbilical cord blood cells. Stem Cells. 1999;17(1):19–24.
   PubMed Web of Science ®Google Scholar
• Ye ZQ, Burkholder JK, Qiu P, Schultz JC, Shahidi NT, Yang NS. Establishment of an adherent cell feeder layer from human umbilical cord blood for support of long-term hematopoietic progenitor cell growth. Proc Natl Acad Sci USA. 1994;91(25):12140–4.
   PubMed Web of Science ®Google Scholar
• Xie CG, Wang JF, Xiang Y, Jia BB, Qiu LY, Wang LJ, et al. Huanga. Marrow mesenchymal stem cells transduced with TPO/FL genes as support for ex vivo expansion of hematopoietic stem/progenitor cells. Cell Mol Life Sci. 2005;62(21):2495–507.
   PubMed Web of Science ®Google Scholar
• Xie CG, Wang JF, Xiang Y, Qiu LY, Jia BB, Wang LJ, et al. Cocultivation of umbilical cord blood CD34+ cells with retro-transduced hMSCs leads to effective amplification of long-term culture-initiating cells. World J Gastroenterol. 2006;12(3):393–402.
   PubMed Web of Science ®Google Scholar
• Kögler G, Callejas J, Sorg RV, Fischer J, Migliaccio AR, Wernet P. The effect of different thawing Methods, growth factor combinations and media on the ex vivo expansion of umbilical cord blood primitive and committed progenitors. Bone Marrow Transplant. 1998;21(3):233–41.
   PubMed Web of Science ®Google Scholar
• Verfaillie CM. Hematopoietic stem cells for transplantation. Nat Immunol. 2002;3(4):314–7.
   PubMed Web of Science ®Google Scholar
• Alakel N, Jing D, Muller K, Bornhauser M, Ehninger G, Ordemann R. Direct contact with mesenchymal stromal cells affects migratory behavior and gene expression profile of CD133 hematopoietic stem cells during ex vivo expansion. Exp Hematol. 2009;37(4):504–13.
   PubMed Web of Science ®Google Scholar
• Wilson A, Trumpp A. Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol. 2006;6(2):93–106.
   PubMed Web of Science ®Google Scholar
• Gottschling S, Saffrich R, Seckinger A, Krause U, Horsch K, Miesala K, et al. Human mesenchymal stromal cells regulate initial self-renewing divisions of hematopoietic progenitor cells by a beta1-integrin-dependent mechanism. Stem Cells. 2007;25(3):798–806.
   PubMed Web of Science ®Google Scholar
• Wagner W, Wein F, Roderburg C, Saffrich R, Faber A, Krause U, et al. Adhesion of hematopoietic progenitor cells to human mesenchymal stem cells as a model for cell–cell interaction. Exp Hematol. 2007;35(2):314–25.
   PubMed Web of Science ®Google Scholar
• Leary SC, Winge DR. The Janus face of copper: it's expanding roles in biology and the pathophysiology of disease. EMBO Rep. 2007;8(3):224–7.
   PubMed Web of Science ®Google Scholar
• Chen CT, Shih YR, Kuo TK, Lee OK, Wei YH. Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells. Stem Cells. 2008;26(4):960–8.
   PubMed Web of Science ®Google Scholar
• Ito K, Hirao A, Arai F, Matsuoka S, Takubo K, Hamaguchi K, et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature. 2004;431:997–1002.
   PubMed Web of Science ®Google Scholar